Ying‐Bei Chen

This study identifies developmental reversion to embryonic nephrogenesis in kidney cancer cells as a mechanism of resistance to immune checkpoint inhibitors.

This paper introduces a pooled sequencing strategy to address intratumoral genetic heterogeneity in cancer, showing it improves mutation detection and risk stratification while reducing costs.